Only 52% Of Pregnant Women In Kaduna State Access Malaria Preventive Drugs – SuNMAP2, Malaria Consortium-GP

0
137
AMDF Coordinator, Sekyen Dadik (second left) giving her remarks at the Media Round Table on 2019 World Malaria Day with a theme: 'Zero Malaria Starts With Me', held at the Nigeria Union of Journalists (NUJ), Kaduna State secretariat on Wednesday April 24, 2019.
By; JACOB ONJEWU DICKSON
There is need to stock more Sulphadoxine Pyrimethamine (SP) used for preventing malaria in pregnant women as only 52 per cent assesses the drugs in the year 2018 in Kaduna State.
The statistics were reeled out at the Media Round Table on 2019 World Malaria Day with a theme: ‘Zero Malaria Starts With Me’, held at the Nigeria Union of Journalists (NUJ), Kaduna State secretariat on Wednesday April 24, 2019.
According to the data made available, out of 258,430 women that attended antenatal services in the state in 2018, only 162,436 of them assessed the second dose of SP.
The statistics, which were made available by the Support to National Malaria Programme 2 (SuNMAP2) and Malaria Consortium – Global Fund GP)should provoke non state and state actors to actions that would make SP available to all pregnant women from the fourth moth of conception.
State Technical Office Malaria Consortium – Global Fund, Dr. Firima Augustine explained that It took a rigorous progress through studies and it has been certified by WHO and recommended to be used during pregnancy, hence it is safe.
“Malaria on pregnancy is preventable and treatable, so no woman should die of malaria,” he added.
He explained that prior to its use as a preventive drug, it used to be used for treating malaria in the past.
“SP was used for prevention of malaria, ab initio, it was used for treatment before it proved to be trusted for preventing it,” he added.
He stressed that there is still need for more funding to meet other needs of women

LEAVE A REPLY

Please enter your comment!
Please enter your name here